Related Experiment Video
Updated: Mar 20, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
[Cognitive disorders in stroke patients: the possibilities of pharmacological correction]
G N Belskaya1, S E Chuprina2, A A Vorobyev2
1South-Ural State Medical University, Chelyabinsk, Russia.
Objective:
To determine the efficacy and safety of cellex in treatment of cognitive disorders in acute ischemic stroke (IS).
Material And Methods:
The study involved 246 patients with acute IS. Patients were randomly divided into two groups depending on the use of cellex or placebo along with basic treatment during 10 days. The dynamics of neuropsychological status was evaluated.
Results And Conclusion:
In IS patients, treatment with cellex have led to more rapid and marked reduction of mild and moderate cognitive disorders.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Psychosis: Goals of Pharmacotherapy
Atherosclerosis IV: Nursing Management

